TBI-223
- Generic Name
- TBI-223
Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
Phase 2
Suspended
- Conditions
- Pulmonary Tuberculosis
- Interventions
- First Posted Date
- 2024-01-05
- Last Posted Date
- 2025-04-23
- Target Recruit Count
- 315
- Registration Number
- NCT06192160
- Locations
- 🇧🇼
12701, Gaborone CRS, Gaborone, Botswana
🇧🇷12201, Hospital Nossa Senhora da Conceicao CRS, Porto Alegre, Brazil
🇧🇷12101, Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS, Rio De Janeiro, Brazil
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath